Featured Research

from universities, journals, and other organizations

Coordinated intervention reduced prevalence of drug-resistant CRE in long-term care

Date:
June 11, 2014
Source:
Society for Healthcare Epidemiology of America
Summary:
A nationwide effort to control carbapenem-resistant Enterobacteriaceae in Israel reduced CRE cases by improving compliance of infection control standards and using a coordinated intervention focused on long-term care facilities researchers report. Since 2006, Israel has faced a nationwide outbreak of CRE throughout its healthcare system.

A new study found a nationwide effort to control carbapenem-resistant Enterobacteriaceae (CRE) in Israel reduced CRE cases by improving compliance of infection control standards and using a coordinated intervention focused on long-term care facilities. The study was published in the July issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

"As the global threat of CRE continues to rise, there is a need to better control and understand this bacteria," said Debby Ben-David, MD, a lead author of the study. "Broadening our focus to long-term care facilities made an impact and reduced the prevalence of these infections, demonstrating the need to look beyond acute care hospitals in our infection control interventions."

Since 2006, Israel has faced a nationwide outbreak of CRE throughout its healthcare system. A 2008 cross-sectional prevalence survey conducted in Israeli post-acute care hospitals (PACHs), similar to long term acute care hospitals in the U.S., revealed a high prevalence of CRE carriage in PACH patients. The transfer of colonized patients between acute care hospitals to PACHs and back again fosters the spread of these drug-resistant infections in healthcare institutions. Based on these results, the Israeli National Center for Infection Control (NCIC) initiated a multifaceted intervention in all PACHs, as part of a national program involving all healthcare facilities in the country.

The intervention included: 1) on-site assessments of infection control policies and practices; 2) CRE isolation guidelines targeted to long-term care facilities; 3) mandatory census reporting of CRE carriers sent to NCIC to facilitate monitoring, compliance with guidelines and track infected patient movement into and out of these facilities; and 4) follow-up surveys of CRE carriage in patients to assess the impact of the intervention on carrier prevalence.

The four-year prospective cohort interventional study found a direct correlation between hospitals with a high infection control score from the on-site assessment and a lower risk of newly discovered CRE carriage. Healthcare facilities' compliance with infection control practices, as measured through on-site assessments, increased more than twofold (score of 6.8 to 14.2 out of 16) and the overall carrier prevalence decreased by approximately 25 percent.

The intervention, carried out in the context of a nationwide initiative to contain CRE spread in healthcare facilities, was based on an understanding of the importance of centrally coordinated regional intervention to contain the spread of multidrug-resistant organisms.


Story Source:

The above story is based on materials provided by Society for Healthcare Epidemiology of America. Note: Materials may be edited for content and length.


Journal Reference:

  1. Debby Ben-David, Samira Masarwa, Amos Adler, Hagit Mishali, Yehuda Carmeli, Mitchell J. Schwaber. A National Intervention to Prevent the Spread of Carbapenem-Resistant Enterobacteriaceae in Israeli Post-Acute Care Hospitals. Infection Control and Hospital Epidemiology, 2014; 35 (7): 802 DOI: 10.1086/676876

Cite This Page:

Society for Healthcare Epidemiology of America. "Coordinated intervention reduced prevalence of drug-resistant CRE in long-term care." ScienceDaily. ScienceDaily, 11 June 2014. <www.sciencedaily.com/releases/2014/06/140611171004.htm>.
Society for Healthcare Epidemiology of America. (2014, June 11). Coordinated intervention reduced prevalence of drug-resistant CRE in long-term care. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/06/140611171004.htm
Society for Healthcare Epidemiology of America. "Coordinated intervention reduced prevalence of drug-resistant CRE in long-term care." ScienceDaily. www.sciencedaily.com/releases/2014/06/140611171004.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins